Evaluation and Management of Fatigue in Patients with Systemic, Autoimmune Rheumatic Disease
摘要
Purpose of review
To summarize current approaches to the evaluation and treatment of fatigue in patients with systemic, autoimmune rheumatic diseases (SARD).
Recent findingsThe mechanisms of fatigue in SARD include both disease-related (peripheral) and individual general health (central) factors and both need to be measured and understood. Fibromyalgia is the most important co-morbidity to account for persistent fatigue in the SARD.
SummaryPain and fatigue are closely aligned.The discordance between fatigue measures and disease activity is explained by central, rather than peripheral mechanisms. When targeted pharmacologic treatment achieves disease remission, residual significant fatigue and pain need to be treated with individualized, biopsychosocial management.